Australia - English - Department of Health (Therapeutic Goods Administration)

neomedix systems pty ltd - 14307 - urodynamic measurement system - the neomedix systems acquidata is a pc based data acquisition system to provide the ability to obtain recorded measurements, and graphical display of physiological changes obtained from a patient to aid in the diagnosis of disorders of the pelvic floor and lower urinary tract.

Australia - English - Department of Health (Therapeutic Goods Administration)

j b medical supplies pty ltd t/a laborie medical technologies australia - 62244 - urodynamic manometric catheter, non-electronic - the t-doc anorectal manometry catheter is a disposable catheter designed for all aspects of anorectal manometry studies

Australia - English - Department of Health (Therapeutic Goods Administration)

j b medical supplies pty ltd t/a laborie medical technologies australia - 62244 - urodynamic manometric catheter, non-electronic - the t-doc anorectal manometry catheter is a disposable catheter designed for all aspects of anorectal manometry studies.

Australia - English - Department of Health (Therapeutic Goods Administration)

j b medical supplies pty ltd t/a laborie medical technologies australia - 14307 - urodynamic measurement system - for diagnosis/study of the bladder. measurement of urinary flow rate, urethral pressure, bladder capacity and response, electromyogram (emg) recording, the measurement of sphincter and other muscle activity. this is used to identify the cause of abnormal voiding, including incontinence, stress incontinence, urinary path obstruction, or spastic sphincters.

Canada - English - Health Canada

sandoz canada incorporated - levobunolol hydrochloride - liquid - 0.25% - levobunolol hydrochloride 0.25% - beta-adrenergic agents

Canada - English - Health Canada

sandoz canada incorporated - levobunolol hydrochloride - liquid - 0.5% - levobunolol hydrochloride 0.5% - beta-adrenergic agents

United States - English - NLM (National Library of Medicine)

a-s medication solutions - ziprasidone mesylate (unii: 3x6sax83jz) (ziprasidone - unii:6uka5vej6x) - geodon is indicated for the treatment of schizophrenia, as monotherapy for the acute treatment of bipolar manic or mixed episodes, and as an adjunct to lithium or valproate for the maintenance treatment of bipolar disorder. geodon intramuscular is indicated for acute agitation in schizophrenic patients. when deciding among the alternative treatments available for the condition needing treatment, the prescriber should consider the finding of ziprasidone's greater capacity to prolong the qt/qtc interval compared to several other antipsychotic drugs [see warnings and precautions (5.3)] . prolongation of the qtc interval is associated in some other drugs with the ability to cause torsade de pointes-type arrhythmia, a potentially fatal polymorphic ventricular tachycardia, and sudden death. in many cases this would lead to the conclusion that other drugs should be tried first. whether ziprasidone will cause torsade de pointes or increase the rate of sudden death is not yet known [see warnings and precautions (5.3)]

Ireland - English - HPRA (Health Products Regulatory Authority)

pfizer limited - ziprasidone hydrochloride monohydrate - pdr+solv for soln for inj - 20 base milligrams

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - terazosin hydrochloride - oral tablet - 2mg

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - terazosin hydrochloride - oral tablet - 2mg